BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 434804)

  • 21. Synthesis and antitumor properties of 7-deoxy-7-[(cis- and trans-3-aminocyclohexane)thio]carminomycinone.
    Essery JM; Doyle TW; Schreiber RH
    J Med Chem; 1979 Nov; 22(11):1425-8. PubMed ID: 160462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytostatic action of semisynthetic derivatives of carminomycin].
    Volkolupova OP; Makukho LV
    Antibiotiki; 1982 Feb; 27(2):145-7. PubMed ID: 7065650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and biological evaluation of 4-O-demethyldaunorubicin (carminomycin I) and of its 13-dihydro derivative.
    Cassinelli G; Grein A; Masi P; Suarato A; Bernardi L; Arcamone F; Di Marco A; Casazza AM; Pratesi G; Soranzo C
    J Antibiot (Tokyo); 1978 Mar; 31(3):178-84. PubMed ID: 649513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Minor components from the carminomycin complex].
    Zbarskiĭ VB; Potapova NP; Olsuf'eva EN; Rubasheva LM; Brazhnikova MG
    Antibiotiki; 1980 Jul; 25(7):492-5. PubMed ID: 6250461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative characteristics of the antitumor and immunodepressive activity of carminomycin on the L-1210 experimental model].
    Berezina TA; Uteshev BS
    Antibiotiki; 1979 Oct; 24(10):767-71. PubMed ID: 496420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [14-O-hemiesters and 13-hydrazones of anthracyline antibiotics of the daunorubicin series. Synthesis and cytostatic activity with respect to tumor cells sensitive or resistant to doxorubicin].
    Povarov LS; Leont'eva OV; Bernaki PD; Olsuf'eva EN; Salimova EI; Pera P; Preobrazhenskaia MN
    Bioorg Khim; 1995 Dec; 21(12):925-32. PubMed ID: 8602889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of the structure of anthracycline antibiotics by ERIAD mass spectrometry].
    Mirgorodskaia OA; Olsuf'eva EN; Matveeva ER; Podmelezhnikov AV
    Bioorg Khim; 1991 Apr; 17(4):556-60. PubMed ID: 1888343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Structure of carminomycins II and III].
    Zbarskiĭ VB; Potapova NP; Brazhnikova MG; Rozynov BV; Sibel'dina LA
    Antibiotiki; 1980 Jul; 25(7):488-92. PubMed ID: 6250460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Determination of carminomycin in its preparations by high-performance liquid chromatography].
    Aleksandrova LG; Rubasheva LM; Zbarskiĭ VB; Brazhnikova MG
    Antibiot Khimioter; 1988 Aug; 33(8):574-8. PubMed ID: 3196114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preparation of tritium-labelled carminomycin and rubomycin by the isotope-exchange method with tritiated water and the determination of the label stability in aqueous solutions].
    Karpov VL; Dedenkov AN
    Antibiotiki; 1981 Apr; 26(4):257-8. PubMed ID: 7235665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ["Chimeric" antibiotics, daunorubicin and its analogs N-acylated with bruneomycin (Streptonigrin)].
    Tolstikov VV; Kozlova NV; Iartseva IV; Preobrazhenskaia MN
    Bioorg Khim; 1989 Feb; 15(2):277-80. PubMed ID: 2500939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The synthesis of epsilon-rhodomycinone- and carminomycin-11-methyl ethers.
    Essery JM; Doyle TW
    J Antibiot (Tokyo); 1979 Mar; 32(3):247-9. PubMed ID: 457585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of the structure of new anthracycline antibiotics on their biological properties.
    Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
    Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of the effects of carminomycin 13-cyclohexylidenehydrazone and carminomycin on several immunologic responses of the body].
    Malkova IV; Shapovalova SP
    Antibiotiki; 1984 May; 29(5):374-7. PubMed ID: 6378085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiviral action of carminomycin and some of its derivatives].
    Liashenko VA; Shapovalova SP; Aleksander SK; Povarov LS
    Antibiotiki; 1978 Nov; 23(11):1009-15. PubMed ID: 214027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Derivatives of antineoplastic antibiotics of the daunorubicin series containing methylurea or nitrosomethylurea residues].
    Povarov LS; Bakina EV; Lazhko EI; Orlova GI; Zhukova OS; Obidniak NA; Iurchenko GI; Glazkova TIu; Preobrazhenskaia MN
    Bioorg Khim; 1990 Apr; 16(4):559-68. PubMed ID: 2375780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Semisynthetic derivatives of daunorubicin and carminomycin: inhibition of DNA synthesis after intravenous administration to mice].
    Reznikova MI; Dudnik IuV
    Antibiot Khimioter; 1988 Sep; 33(9):653-7. PubMed ID: 3218988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Determination of carminomycin and its basic metabolite 13-dihydrocarminomycin by a highly efficient liquid chromatographic method with a fluorescent detector].
    Poteshnykh AV; Shevchenko VE
    Antibiotiki; 1982 Nov; 27(11):820-3. PubMed ID: 7181464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anthracycline antibiotics and their derivatives--inhibitors of topoisomerase I].
    Dezhenkova LG; Teviashova AN; Olsuf'eva EN; Treshchalin ID; Shtil' AA; Preobrazhenskaia MN
    Bioorg Khim; 2008; 34(3):430-2. PubMed ID: 18672696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of [(N-morpholine)metylene]daunorubicin hydrochloride in solid state.
    Zalewski P; Jelińska A; Prusinowska P; Cielecka-Piontek J; Krause A; Oszczapowicz I
    Acta Pol Pharm; 2011; 68(5):759-63. PubMed ID: 21928722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.